Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension

NCT04518293 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1385

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg
DRUG: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg
DRUG: Telmisartan 20 mg/amlodipine 2.5 mg
DRUG: telmisartan 40 mg/amlodipine 5 mg
DRUG: Telmisartan 20 mg/indapamide 1.25 mg
DRUG: telmisartan 40 mg/indapamide 2.5 mg
DRUG: Amlodipine 2.5 mg/indapamide 1.25 mg
DRUG: amlodipine 5 mg/indapamide 2.5 mg

Sponsor

George Medicines PTY Limited